206
Views
46
CrossRef citations to date
0
Altmetric
Reviews

Nonalcoholic Fatty Liver Disease in Children

, MD, PhD, , MD, , MD, , MD, , MD, PhD, FACN & , MD
Pages 667-676 | Received 19 Mar 2008, Accepted 22 Jul 2008, Published online: 14 Jun 2013

REFERENCES

  • Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE: Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.J Pediatr Gastroenterol Nutr43 :413– 427,2006 .
  • Manco M, Marcellini M, DeVito R, Comparcola D, Sartorelli MR, Nobili V: Metabolic syndrome and liver histology in paediatric non alcoholic steatohepatitis.Int J Obes (Lond)32 :381– 387,2008 .
  • Fraser A, Longnecker MP, Lawlor DA: Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.Gastroenterology133 :1814– 1820,2007 .
  • Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C: Prevalence of fatty liver in children and adolescents.Pediatrics118 :1388– 1393,2006 .
  • Strauss RS, Barlow SE, Dietz WH: Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents.J Pediatr136 :727– 733,2000 .
  • Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, Bedogni G: Predictors of non-alcoholic fatty liver disease in obese children.Eur J Clin Nutr61 :877– 883,2007 .
  • Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, Nelson EA: Hepatic steatosis in obese Chinese children.Int J Obes Relat Metab Disord28 :1257– 1263,2004 .
  • Nadeau KJ, Klingensmith G, Zeitler P: Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.J Pediatr Gastroenterol Nutr41 :94– 98,2005 .
  • Adams LA, Lymp JF, St. Sauver J, Sanderson SO, Lindor KD, Feldstein AM, Angulo P: The natural history of nonalcoholic fatty liver disease: a population-based cohort study.Gastroenterology129 :113– 121,2005 .
  • Angulo P: Nonalcoholic fatty liver disease.N Engl J Med346 :1221– 1231,2002 .
  • Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE: Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.Pediatrics115 :E561– E565,2005 .
  • Day CP, James OF: Steatohepatitis: a tale of two “hits”?Gastroenterology114 :842– 845,1998
  • Day CP: From fat to inflammation.Gastroenterology130 :207– 210,2006 .
  • Nobili V, Marcellini M, Marchesini G, Vanni E, Manco M, Villani A, Bugianesi E: Intrauterine Growth Retardation, Insulin Resistance, and Nonalcoholic Fatty Liver Disease in Children.Diabetes Care30 :2638– 2640,2007 .
  • Barker DJ: Fetal programming of coronary heart disease.Trends Endocrinol Metab13 :364– 368,2002 .
  • Gruenwald P: Chronic fetal distress and placental insufficiency.Biol Neonat5 :215– 65,1963
  • Bugianesi E, McCullogh AJ, Marchesini G: Insulin resistance: a metabolic pathway to chronic liver disease.Hepatology42 :987– 1000,2005 .
  • Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M: Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.Hepatology35 :367– 372,2002 .
  • Tiikkainen M, Hakkinen AM, Korsheninnikova E, Nyman T, Makimattila S, Yki-Jarvinen H: Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.Diabetes53 :2169– 2176,2004 .
  • Utzschneider KM, Kahn SE: Review: The role of insulin resistance in nonalcoholic fatty liver disease.J Clin Endocrinol Metab91 :4753– 4761,2006 .
  • Azzout-Marniche D, Becard D, Guichard C, Foretz M, Ferre P, Foufelle F: Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes.Biochem J350 :389– 393,2000 .
  • Browning JD, Horton JD: Molecular mediators of hepatic steatosis and liver injury.J Clin Invest114 :147– 152,2004 .
  • Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ: Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.J Clin Investl15 :1343– 1351,2005 .
  • Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML and Clore JN: Non alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.Gastroenterology120 :1183– 1192,2001 .
  • Leclerq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A: Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences.J Hepatol47 :142– 156,2007 .
  • Manco M, Marcellini M, Giannone G, Nobili V: Correlation of serum TNF-alpha levels and histologic liver injury scores in paediatric non-alcholic fatty liver disease.Am J Clin Pathol127 :954– 960,2007 .
  • Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, Comparcola D, Guidi R, Marcellini M: Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.Eur J Endocrinol155 :735– 743,2006 .
  • Zou CC, Liang L, Hong F, Fu JF, Zhao ZY: Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children.Endocr J52 :519– 524,2005 .
  • Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, Sartorelli MR, Comparcola D, Piemonte F, Nobili V: Waist circumference correlates with liver fibrosis in children with non alcoholic steatohepatitis.Gut57 :1283– 1287,2008 .
  • Keskin M, Kurtoglu S, Kendrici M, Atabek ME, Yazici C: Homeostasis model assessment is more reliable than the fasting glucose/insulin and quantitative insulin sensitivity index for assessing insulin resistance among obese children and adolescents.Pediatrics115 :E500– E503,2005 .
  • Uwaifo GI, Tjahjana M, Freedman RJ, Lutchman G, Promrat K: Acanthosis nigricans in patients with nonalcoholic steatohepatitis: an uncommon finding.Endocr Pract12 :371– 379,2006 .
  • Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS: Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.Arch Intern Med164 :2169– 2175,2004 .
  • Matsuda M, De Fronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes Care22 :1462– 1470,1999 .
  • Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.Diabetes Care24 :539– 548,2001 .
  • DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance.Am J Physiol237 :E214– E223,1979 .
  • Bergman RN: Lilly lecture 1989.Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes38 :1512– 1527,1989 .
  • American Diabetes Association: Diagnosis and classification of Diabetes Mellitus.Diabetes Care31 :S55– S60,2008 .
  • Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP: The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.Hepatology45 :846– 854,2007 .
  • Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ: European Liver Fibrosis Group. Serum markers detect the presence of liver fibrosis: a cohort study.Gastroenterology127 :1704– 1713,2004 .
  • Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M: Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.Hepatology2008 Apr 18.
  • Schwimmer JB, Behling C, Newbury R, Dcutsch R, Nievergelt C, Schork NJ, Lavine JE: Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology42 :641– 649,2005
  • Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, Sartorelli MR, Angulo P: NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.Hepatology44 :458– 465,2006 .
  • Roberts EA: Pediatric nonalcholic fatty liver disease (NAFLD): A “growing” problem?J Hepatol46 :1133– 1142,2007 .
  • Brunt EM: Non-alcoholic steatohepatitis: definition and pathology.Semin Liver Dis21 :3– 16,2001 .
  • Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ: Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology41 :1313– 1321,2005 .
  • Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P: Lifestyle intervention and antioxidants in children with non alcoholic fatty liver disease: a randomised controlled trial.Hepatology48 :119– 128,2008 .
  • Zivkovic AM, German JB, Sanyal AJ: Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.Am J Clin Nutr86 :285– 300,2007 .
  • Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, Magnuson T: Dietary composition and nonalcoholic fatty liver disease.Dig Dis Sci49 :1578– 1583,2004 .
  • Anderson JW, Randles KM, Kendall CW, Jenkins DJ: Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence.J Am Coll Nutr23 :5– 17,2004 .
  • Popkin BM, Armstrong LE, Bray GM, Caballero B, Frei B, Willett WC: A new proposed guidance system for beverage consumption in the United States.Am J Clin Nutr83 :529– 542,2006 .
  • McDevitt RM, Bott SJ, Harding M, Coward WA, Bluck LJ, Prentice AM. De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women.Am J Clin Nutr74 :737– 746,2001 .
  • Teff KL, Elliott SS, Tschop M, Kiefer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ: Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.J Clin Endocrinol Metab89 :2963– 2972,2004 .
  • Wang D, Wei Y, Pagliassotti MJ: Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis.Endocrinology147 :943– 51,2006 .
  • Manco M, Calvani M, Mingrone G: Effects of dietary fatty acids on insulin sensitivity and secretion.Diabetes Obes Metab6 :402– 413,2004 .
  • Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB; Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.J Nutr135 :562– 566,2005 .
  • Mozaffarian D: Trans fatty acids—effects on systemic inflammation and endothelial function.Atheroscler Suppl7 :29– 32,2006 .
  • Tricon S, Burdge GC, Kew S, Banerjee T, Russell JJ, Jones EL, Grimble RF, Williams CM, Yaqoob P, Calder PC: Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans.Am J Clin Nutr80 :614– 620,2004 .
  • Tricon S, Burdge GC, Jones EL, Russell JJ, El-Khazen S, Moretti E, Hall WL, Gerry AB, Leake DS, Grimble RF, Williams CM, Calder PC, Yaqoob P: Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men.Am J Clin Nutr83 :744– 753,2006 .
  • Lichtenstein AH. Thematic review series: patient-oriented research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns.J Lipid Res47 :1661– 1667,2006 .
  • Vinciguerra M, Veyrat-Durebex C, Moukil MA, Rubbia-Brandt L, Rohner-Jeanrenaud F, Foti M: PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF kappaBp65/mTOR-dependent mechanism.Gastroenterology.134 :268– 280,2008 .
  • Goheen SC, Larkin EC, Rao GA: Severe fatty liver in rats fed a fat-free ethanol diet, and its prevention by small amounts of dietary arachidonate.Lipids18 :285– 290,1983 .
  • Bouziane M, Prost J, Belleville J: Dietary protein deficiency affects n-3 and n-6 polyunsaturated fatty acids hepatic storage and very low density lipoprotein transport in rats on different diets.Lipids29 :265– 272,1994 .
  • Clarke SD, Jump DB: Polyunsaturated fatty acid regulation of hepatic gene transcription.Lipids31 :S7– S11,1996 .
  • Kim HJ, Takahashi M, Ezaki O: Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs.J Biol Chem274 :25892– 25898,1999 .
  • Marchesini G, Brizi M, Bianchi G: Metformin in non-alcoholic steatohepatitis.Lancet358 :893– 894,2001 .
  • Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM: Metformin reverses fatty liver disease in obese, leptin-deficient mice.Nat Med6 :998– 1003,2000 .
  • Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.N Engl J Med355 :2297– 2307,2006 .
  • Lavine JE, Schwimmer JB: Clinical Research Network launches TONIC: trial for treatment of non alcoholic fatty liver disease in children.J Pediatr Gastroenterol Nutr42 :129– 130,2006 .
  • Schwimmer JB, Middleton MS, Deutsch R, Lavine JE: A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.Aliment Pharmacol Ther21 :871– 879,2005 .
  • Lavine JE: Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.J Pediatr136 :734– 738,2000 .
  • Vajro P, Mandato C, Franzese A, Ciccimarra E, Lucariello S, Savoia M, Capuano G, Migliaro F: Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.J Pediatr Gastroenterol Nutr.38 :48– 55,2004 .
  • Nobili V, Manco M, DeVito R, Ciampalini P, Piemonte F, Marcellini M: Effect of vitamin E on aminotransferase levels and insulin resistance in NAFLD children.Aliment Pharmacol Ther24 :1553– 1561,2006 .
  • Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G: Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study.Clin Ther30 :1168– 1176,2008 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.